Vilon
Lys-Glu (KE)
Vilon is a synthetic dipeptide with laboratory findings on chromatin and inflammatory signaling, not established lifespan extension.
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
The cited primary literature defines the tested Vilon as the synthetic dipeptide Lys-Glu. This assignment does not validate commercial products with other compositions.
- Human research
- None
- Replication
- Single research group
- Clinical endpoints
- No clinical endpoints
- Safety
- Not adequately studied
- Approval
- No documented approval
The dimensions are presented separately and are not combined into an overall score.
What the source shows
Both studies occurred outside the body and examined Vilon alongside other peptides.
- Anti-aging peptide bioregulators induce reactivation of chromatinLaboratory study2006
Lezhava T et al.
Accessed:
- Peptides regulating proliferative activity and inflammatory pathways in the monocyte/macrophage THP-1 cell lineLaboratory study2022
Avolio F et al.
Accessed:
Research gaps
- ·Cultured cells establish neither lifespan extension nor immune benefit in humans. The evidence lacks independent clinical replication.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
Reports describe chromatin deheterochromatinization and altered signaling in cultured immune cells; this is not a validated clinical mechanism.
- Anti-aging peptide bioregulators induce reactivation of chromatinLaboratory study2006
Lezhava T et al.
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Evidence is insufficient; absence of data is not evidence of safety. Controlled human exposure, pharmacokinetics, long-term toxicology, contraindications and interactions are absent.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·Cultured cells establish neither lifespan extension nor immune benefit in humans. The evidence lacks independent clinical replication.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- Anti-aging peptide bioregulators induce reactivation of chromatinLaboratory study2006
Lezhava T et al.
Accessed:
Sources
Sources checked: · Version 3
- Anti-aging peptide bioregulators induce reactivation of chromatinLaboratory study2006
Lezhava T et al.
Accessed:
- Peptides regulating proliferative activity and inflammatory pathways in the monocyte/macrophage THP-1 cell lineLaboratory study2022
Avolio F et al.
Accessed: